Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;219(1):54-57.
doi: 10.1016/j.amjsurg.2019.07.039. Epub 2019 Jul 29.

Improved prediction of HIT in the SICU using an improved model of the Warkentin 4-T system: 3-T

Affiliations

Improved prediction of HIT in the SICU using an improved model of the Warkentin 4-T system: 3-T

Matthew B Bloom et al. Am J Surg. 2020 Jan.

Abstract

Background: The Warkentin 4-T scoring system for determining the pretest probability of heparin-induced thrombocytopenia (HIT) has been shown to be inaccurate in the ICU and does not take into account body mass index (BMI).

Methods: Prospectively collected data on patients in the surgical and cardiac ICU between January 2007 and February 2016 who were presumed to have HIT by clinical suspicion were reviewed. Patients were categorized into 3 BMI groups and assigned scores: Normal weight, overweight, and obese. Multivariate analyses were used to identify independent predictors of HIT.

Results: A total of 523 patients met inclusion criteria. Multivariate analysis showed that only BMI, Timing, and oTher variables were independently associated with HIT. This new 3-T model was better than a five-component model consisting of the entire 4-T scoring system plus BMI (AUC = 0.791).

Conclusions: Incorporating patient 'T'hickness into a pretest probability model along with platelet 'T'iming and the exclusion of o'T'her causes of thrombocytopenia yields a simplified "3-T" scoring system that has increased predictive accuracy in the ICU.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors declare no conflicts of interest.

References

    1. Warkentin TE. Heparin-induced thrombocytopenia. Curr Opin Crit Care. 2015. December;21(6):576–585. - PubMed
    1. Arepally GM. Heparin-induced thrombocytopenia. Blood. 2017. May 25;129(21):2864–2872. - PMC - PubMed
    1. Khandelwal S, Arepally GM. Immune pathogenesis of heparin-induced thrombocytopenia. Thromb Haemost. 2016. October 28;116(5):792–798. - PMC - PubMed
    1. Linkins L-A, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis In: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. ninth ed. 2012:e495S–e530S. - PMC - PubMed
    1. Visentin GP, Malik M, Cyganiak KA, Aster RH. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. J Lab Clin Med. 1996;128(4): 376–383. - PubMed

Publication types